Zydus receives final approval from USFDA for Ketoconazole Shampoo, 2%

2025-03-10 07:46:00

(MENAFN- Adfactors PR) Bengaluru, 10 March, 2025

Zydus Lifesciences Limited (including its subsidiaries/ affiliates, hereafter referred to as “Zydus”) has received final approval from the United States Food and Drug Administration (USFDA) to manufacture Ketoconazole Shampoo, 2% (USRLD: Nizoral® Shampoo, 2%).

Ketoconazole shampoo is an antifungal medication used to treat dandruff, fungal infections, and other skin conditions. Ketoconazole shampoo will be produced at the Group’s topical manufacturing site at Changodar, Ahmedabad.

Ketoconazole shampoo had annual sales of USD 68.89 mn in the United States (IQVIA MAT January 2025).

The group now has 418 approvals and has so far filed 483* ANDAs since the commencement of the filing process in FY 2003-04.

(*As on 31st December, 2024.)

MENAFN10032025005232011781ID1109296421

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.